ELI LILLY AND COMPANY LIMITED - United Kingdom 

Ranking results:

Past rankings:

Subject specific rankings are not yet available..

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2014 0 8.207.244 414.860 2
2011 0 6.000.000 0 1

Networking:

Partners:

Institution:Projects [No]:
JANSSEN PHARMACEUTICA NV19
NOVARTIS PHARMA14
F HOFFMANNLA ROCHE12
PFIZER LIMITED12
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD12
SANOFIAVENTIS11
TAKEDA DEVELOPMENT CENTRE EUROPE10
BAYER9
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT9
KING'S COLLEGE LONDON9
NOVO NORDISK9
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE8
UCB BIOPHARMA8
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM6
KATHOLIEKE UNIVERSITEIT LEUVEN6
SIB INSTITUT SUISSE DE BIOINFORMATIQUE6
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL6
TAKEDA PHARMACEUTICALS INTERNATIONAL6
UNIVERSITAIR MEDISCH CENTRUM UTRECHT6
ABBVIE INC5
ALZHEIMER EUROPE5
ASTRAZENECA AB5
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG5
CHARITE UNIVERSITAETSMEDIZIN BERLIN5
H LUNDBECK AS5
KAROLINSKA INSTITUTE5
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN5
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE5
UNIVERSITY OF DUNDEE5
UNIVERSITY OF NEWCASTLE UPON TYNE5
ACADEMISCH ZIEKENHUIS GRONINGEN4
ACADEMISCH ZIEKENHUIS LEIDEN4
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS4
ASTRAZENECA4
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V4
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE4
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS4
MERCK SHARP & DOHME CORP4
REGION HOVEDSTADEN4
SANOFIAVENTIS DEUTSCHLAND4
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT4
STICHTING KATHOLIEKE UNIVERSITEIT4
STICHTING VUMC4
THE UNIVERSITY OF EDINBURGH4
THE UNIVERSITY OF LIVERPOOL4
UNIVERSITEIT MAASTRICHT4
UNIVERSITY OF AARHUS4
AMGEN LIMITED3
ASTELLAS PHARMA EUROPE BV3
FORUM DES PATIENTS EUROPEENS3
FUNDACIO SANT JOAN DE DEU3
INSTITUT DE RECHERCHES SERVIER3
JDRF INTERNATIONAL3
MEDIZINISCHE UNIVERSITAET WIEN3
MEDIZINISCHE UNIVERSITAT INNSBRUCK3
ORION OYJ3
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE3
THE HYVE BV3
THE UNIVERSITY OF MANCHESTER3
UNIVERSITAET ZUERICH3
UNIVERSITAETSKLINIKUM AACHEN3
UNIVERSITAETSKLINIKUM HEIDELBERG3
UNIVERSITE DE LAUSANNE3
UNIVERSITY COLLEGE LONDON3
UNIVERSITY OF BIRMINGHAM3
ABBVIE2
ABBVIE DEUTSCHLAND GMBH & CO KG2
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM2
AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN2
ARTTIC2
BAYER AKTIENGESELLSCHAFT2
BAYER PHARMA2
BIOGEN IDEC LIMITED2
BRISTOLMYERS SQUIBB COMPANY CORP2
CELGENE MANAGEMENT SARL2
CENTRE DE RECHERCHE PUBLIC DE LA SANTE2
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS2
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE2
CHU HOPITAUX DE BORDEAUX2
CONCENTRIS RESEARCH MANAGEMENT2
COVANCE LABORATORIES2
DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV2
EBERHARD KARLS UNIVERSITAET TUEBINGEN2
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK2
ELLEGAARD GOTTINGEN MINIPIGS AS2
EUROPEAN CANCER PATIENT COALITION2
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE2
EUROPEAN INSTITUTE OF WOMEN'S HEALTH COMPANY LIMITED BY GUARANTEE2
EUROPEAN MOLECULAR BIOLOGY LABORATORY2
EURORDIS EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION2
FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES2
FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM2
GOETEBORGS UNIVERSITET2
GRUNENTHAL2
HELSINGIN JA UUDENMAAN SAIRAANHOITOPIIRIN KUNTAYHTYMAE2
INSTITUT CURIE2
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER2
INTERNATIONAL ALLIANCE OF PATIENT'ORGANIZATIONS2
ITASUOMEN YLIOPISTO2
IXSCIENT LIMITED2

Constancy:

Total number of partners: 808
Partner loyalty:
Frequent Partner: (> 2 projects): 355
Rare Partner: 453
Frequent / Rare Partner Ratio: 0.78

Project overview:

Start dateProjectacronymrolefundingpartners
2014-10-01Diagnostic and Drug Discovery Initiative for Alzheimer’s Disease D3I4ADparticipant2.208.8985
2014-02-01Translating neuroimaging findings from research into clinical practice PSYSCANparticipant5.998.34615
2011-11-01Pharmacogenomic biomarkers as clinical decision making tools for clozapine treatment of schizophrenia CRESTARparticipant6.000.00011